408 related articles for article (PubMed ID: 21889469)
1. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
Björnsson E; Jacobsen EI; Kalaitzakis E
J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
[TBL] [Abstract][Full Text] [Related]
2. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity of statins and other lipid-lowering agents.
Björnsson ES
Liver Int; 2017 Feb; 37(2):173-178. PubMed ID: 27860156
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin associated liver disease.
Clarke AT; Mills PR
Dig Liver Dis; 2006 Oct; 38(10):772-7. PubMed ID: 16777499
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced liver injury associated with statins.
Russo MW; Scobey M; Bonkovsky HL
Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
[TBL] [Abstract][Full Text] [Related]
6. Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2004 Jun; 93(11):1417-8, A9. PubMed ID: 15165929
[TBL] [Abstract][Full Text] [Related]
7. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
Rahier JF; Rahier J; Leclercq I; Geubel AP
Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
Newman C; Tsai J; Szarek M; Luo D; Gibson E
Am J Cardiol; 2006 Jan; 97(1):61-7. PubMed ID: 16377285
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Golomb B; Evans M
Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
[No Abstract] [Full Text] [Related]
10. [Acute cholestatic hepatitis after atorvastatin reintroduction].
de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
[TBL] [Abstract][Full Text] [Related]
11. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Wiviott SD; de Lemos JA; Cannon CP; Blazing M; Murphy SA; McCabe CH; Califf R; Braunwald E
Circulation; 2006 Mar; 113(11):1406-14. PubMed ID: 16534008
[TBL] [Abstract][Full Text] [Related]
12. Severe Liver Injury Associated With High-Dose Atorvastatin Therapy.
Saha A; Garg A
J Investig Med High Impact Case Rep; 2021; 9():23247096211014050. PubMed ID: 33966478
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.
Ramachandran S; Saraf S; Shetty C; Capps N; Bailey C
Ann Clin Biochem; 2011 Jan; 48(Pt 1):75-8. PubMed ID: 21115572
[TBL] [Abstract][Full Text] [Related]
14. Acute hepatic injury with atorvastatin: an unusual occurrence.
Vishwakarma P; Nehra R; Kumar A
Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
[TBL] [Abstract][Full Text] [Related]
16. Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies.
Minha S; Golzman G; Adar I; Rapoport M
Isr Med Assoc J; 2009 Jul; 11(7):440-1. PubMed ID: 19911499
[No Abstract] [Full Text] [Related]
17. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Ronaldson KJ; O'Shea JM; Boyd IW
Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
[TBL] [Abstract][Full Text] [Related]
18. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
[TBL] [Abstract][Full Text] [Related]
19. Safety of high-dose atorvastatin therapy.
Waters DD
Am J Cardiol; 2005 Sep; 96(5A):69F-75F. PubMed ID: 16126026
[TBL] [Abstract][Full Text] [Related]
20. Adverse events with concomitant amiodarone and statin therapy.
Alsheikh-Ali AA; Karas RH
Prev Cardiol; 2005; 8(2):95-7. PubMed ID: 15860984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
